CIK: 0001728001
申报总市值
US$86.9亿
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AEGR 2 08-15-19 | Aegerion Pharmaceuticals | 股票-其他 | 85.94% | — | -11.70% | |
| 2 | PTCT 3 08-15-22 | Ptc Therapeutics INC | 股票-医疗保健 | 7.78% | — | -65.03% | |
| 3 | ✓ | Kala Bio INC Com New | 股票-其他 | 6.28% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | AEGR 2 08-15-19 | Aegerion Pharmaceuticals | +8.6% | -11.70% | 减仓 |
| 2 | PTCT 3 08-15-22 | Ptc Therapeutics INC | -13.5% | -65.03% | 减仓 |
| 3 | ✓ | Kala Bio INC Com New | — | NEW | 新建仓 |
| 4 | HQ8F | Apollo Endosurgery INC | — | EXIT | 清仓 |